Skip to main content
SpringerLink
Log in

Risk-benefit decisions in patient care

  • Chapter
Medicines and Risk/Benefit Decisions

Part of the book series: CMR Workshop Series ((CMRWS))

  • 34 Accesses

Abstract

Various authors have discussed risk-benefit decisions in relation to their predictive aspect for patient care1-3. However, they are not always discussing the same thing, some being concerned most with averaged risks and benefits and others with their impact on individuals. Thus it would appear that there is very little sound information available to help a physician when trying to reach a risk-benefit decision on behalf of, or with, an individual patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brimblecombe, R.W. and Dayan, A.D. (1985). Preclinical toxicity testing. In Burley, D.M. and Binns, T.B. (eds.) Pharmaceutical Medicine, p. 18 (London: Arnold)

    Google Scholar 

  2. Teeling-Smith, G. (1983). In Teeiing-Smith, G. (ed.). Measuring the Social Benefits of Medicine, pp. 163–6 (London: Office of Health Economics.)

    Google Scholar 

  3. Ford, A.R., Aronson, J.K., Grahame-Smith, D.G. and Carver, J.G. (1979). The acute changes seen in cardiac glycoside receptor sites during the early phases of digoxin therapy are not found during chronic therapy. Br. J. Clin. Pharmacol., 8, 135–42

    PubMed  CAS  Google Scholar 

  4. McNeil, Barbara, J., Weidselbaum, R. and Pauker, S.G. (1978). Fallacy of the five year survival in lung cancer. N. Engl. J. Med., 299, 1397–401.

    Article  PubMed  CAS  Google Scholar 

  5. Bulpitt, C.J., Dollery, C.T. and Carne, S. (1976). Change in symptoms of hypertensive patients after referral to hospital clinics. Br. Heart J., 38, 121–8

    Article  PubMed  CAS  Google Scholar 

  6. Johnston, G.C. and McDevitt, D.G. (1979). Is maintenance digoxin necessary in patients with sinus rhythm? Lancet, 1, 567–70

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Professor D. W. Vere
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Carshalton, Surrey, UK

    Stuart R Walker (Director of the Centre for Medicines Research) (Director of the Centre for Medicines Research)

  2. University of Wales College of Medicine Royal Infirmary, Cardiff, UK

    A William Asscher (Professor of Renal Medicine) (Professor of Renal Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 1987 MTP Press Limited

About this chapter

Cite this chapter

Vere, D.W. (1987). Risk-benefit decisions in patient care. In: Walker, S.R., Asscher, A.W. (eds) Medicines and Risk/Benefit Decisions. CMR Workshop Series. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3221-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-3221-0_17

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7946-4

  • Online ISBN: 978-94-009-3221-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation